Teva Pharmaceutical Industries Limited (TEV) — Net Asset Quality Index
Teva Pharmaceutical Industries Limited (TEV) has a Net Asset Quality Index of 20.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €40.04 Billion minus total liabilities of €31.81 Billion yields net assets of €8.23 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Teva Pharmaceutical Industries Limited (TEV) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Teva Pharmaceutical Industries Limited Net Asset Quality Index Over Time (2015–2025)
This chart shows how Teva Pharmaceutical Industries Limited's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the index stands at 20.6%, representing net assets of €8.23 Billion against total assets of €40.04 Billion EUR. See Teva Pharmaceutical Industries Limited (TEV) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Teva Pharmaceutical Industries Limited (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Teva Pharmaceutical Industries Limited from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Teva Pharmaceutical Industries Limited market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 19.4% | €7.91 Billion | €40.75 Billion | €32.83 Billion | ▲ +4.9 pp |
| 2024 | 14.5% | €5.72 Billion | €39.33 Billion | €33.61 Billion | ▼ -4.1 pp |
| 2023 | 18.7% | €8.13 Billion | €43.48 Billion | €35.35 Billion | ▼ -1.1 pp |
| 2022 | 19.7% | €8.69 Billion | €44.01 Billion | €35.31 Billion | ▼ -3.8 pp |
| 2021 | 23.6% | €11.24 Billion | €47.67 Billion | €36.42 Billion | ▲ +1.7 pp |
| 2020 | 21.8% | €11.06 Billion | €50.64 Billion | €39.58 Billion | ▼ -4.4 pp |
| 2019 | 26.2% | €15.06 Billion | €57.47 Billion | €42.41 Billion | ▲ +0.2 pp |
| 2018 | 26.0% | €15.79 Billion | €60.68 Billion | €44.89 Billion | ▼ -0.5 pp |
| 2017 | 26.5% | €18.75 Billion | €70.61 Billion | €51.87 Billion | ▼ -11.1 pp |
| 2016 | 37.7% | €34.99 Billion | €92.89 Billion | €57.90 Billion | ▼ -17.5 pp |
| 2015 | 55.2% | €29.93 Billion | €54.23 Billion | €24.31 Billion | — |